開発:インフレ圧力

Same author

MGMTai: O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) methylation prediction in isocitrate dehydrogenase (<i>IDH</i>)-wild type glioblastoma to direct temozolomide therapy.

Neuro-oncology advances·2026

Same author

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

JAMA network open·2026

Same author

Suction Ureteral Access Sheaths During Flexible Ureteroscopy for Renal Stones: A Prospective Study and Cost Analysis.

Cureus·2025

Same author

Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay.

Oncotarget·2025

Same author

Enhancing biochar quality for the steel industry via Hydrothermal Pretreatment-Steam Explosion and pyrolysis.

Bioresource technology·2025

Same author

GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.

Cancer research communications·2025

Same journal

Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Nature·2026

Same journal

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Nature·2026

Same journal

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Nature·2026

Same journal

Child online safety needs more than social-media bans.

Nature·2026

Same journal

Ebola preparedness must start with ecosystems and before humans show symptoms.

Nature·2026

Same journal

AI tools can speed up thinking, but evidence still comes from the lab bench.

Nature·2026

関連する実験動画

開発:インフレ圧力

関連する概念動画

MGMTai: O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) methylation prediction in isocitrate dehydrogenase (<i>IDH</i>)-wild type glioblastoma to direct temozolomide therapy.

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

Suction Ureteral Access Sheaths During Flexible Ureteroscopy for Renal Stones: A Prospective Study and Cost Analysis.

Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay.

Enhancing biochar quality for the steel industry via Hydrothermal Pretreatment-Steam Explosion and pyrolysis.

GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.

Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Child online safety needs more than social-media bans.

Ebola preparedness must start with ecosystems and before humans show symptoms.

AI tools can speed up thinking, but evidence still comes from the lab bench.

関連する実験動画

開発:インフレ圧力

関連する概念動画

関連記事

MGMTai: O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) methylation prediction in isocitrate dehydrogenase (<i>IDH</i>)-wild type glioblastoma to direct temozolomide therapy.

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

Suction Ureteral Access Sheaths During Flexible Ureteroscopy for Renal Stones: A Prospective Study and Cost Analysis.

Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay.

Enhancing biochar quality for the steel industry via Hydrothermal Pretreatment-Steam Explosion and pyrolysis.

GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.

Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Child online safety needs more than social-media bans.

Ebola preparedness must start with ecosystems and before humans show symptoms.

AI tools can speed up thinking, but evidence still comes from the lab bench.